While I don't know for certain, I will speculate on why this would likely not happen. First you've got the difficulty of treatment. Customers would have to monitor their cholesterol and blood pressure and decide on their own if their self-prescribed treatment is effective.
This is difficult because there are a ton of different classes of cholesterol and BP meds, and within these classes there are quite a few different options. Most customers are ignorant to the process and mechanisms behind treatment and this brings up a legal issue.
Even if Chemone these products legally, cholesterol and BP are life-threatening conditions that if treated properly could bring suit against the company (Chemone).
While it might not go anywhere, it would bring negative publicity to the research chemical industry (at least the AAS-type research chem companies) and could lead to new laws or current laws being more strictly enforced, ultimately leading to the downfall of the industry or a huge cut in profits.
Take-home points: treatment is too difficult for most people to do (let alone some doctors) to do themselves, and this could lead to legal issues and at minimum negative publicity